首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailability.
【24h】

Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailability.

机译:诱导型一氧化氮合酶抑制剂的设计与合成。发现一种具有潜在口服生物利用度的新化学铅。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 2-iminopiperidines fused to small-membered rings () were synthesised and biologically evaluated using an in vitro human nitric oxide synthase (NOS) inhibition assay. Fused bicyclic compounds 5-9 exhibited nearly the same potency as compound 1 in the hiNOS inhibition assay. Among these, the 1-methyl analogues 8 and 9 showed better isoform selectivity than their corresponding unsubstituted analogues 7 and 6, respectively. Compounds 5 and 6 were also evaluated by an in vivo NO accumulation assay in a mouse model. The discovery process of new chemical leads for an orally bioavailable inhibitor of human inducible NOS (iNOS) is reported. The structure-activity relationship (SAR) study and chemistry of these compounds are also reported.
机译:合成了一系列融合在小成员环上的2-亚氨基哌啶,并使用体外人一氧化氮合酶(NOS)抑制试验进行了生物学评估。融合的双环化合物5-9在hiNOS抑制试验中显示出与化合物1几乎相同的功效。其中,1-甲基类似物8​​和9分别显示出比其相应的未取代类似物7和6更好的同工型选择性。还通过在小鼠模型中的体内NO累积测定法评估了化合物5和6。有人发现了口服诱导型NOS(iNOS)的口服生物利用抑制剂的新化学线索的发现过程。还报道了这些化合物的结构活性关系(SAR)研究和化学性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号